Did Oxford’s COVID-19 Vaccine Fail? Some Troubling Questions about ChAdOx123 May 2020 20:35
Think we've had smilar articles, this one seems to be even more "questioning":
https://www.trialsitenews.com/did-oxfords-covid-19-vaccine-fail-some-troubling-questions-about-chadox1/
"...Dr. William Haseltine, writing in Forbes, questioned why they would continue the study in humans. According to Dr. Haseltine, the data—uploaded to preprint server BioRxiv—reveals that actually all of the monkeys exposed to SARS-CoV-2 and treated with the promising Oxford vaccine called ChAdOx1 became infected with the disease when the factoring in the analysis of recovery of virus genomic RNA from nasal secretions. Haseltine continued that the delta between vaccinated monkeys and unvaccinated monkeys was nil. One interpretation of this fact: all of the monkeys were infected by SARS-CoV-2 and hence, the vaccine really doesn’t work! Haseltine contrasts this to recent Sinovac trial, which revealed that those monkeys infected with the highest doses showed no trace of virus from the throat, lung or rectum. Derek Lowe suggests this may not be an “apples to apples” comparison. However, there are complexities that must be considered before making sweeping declarations.
The UK’s Express reported that according to Jonathan Ball, professor of molecular virology at the University of Nottingham, if this same scenario occurred in humans, the vaccine would not serve as a hinderance to the pathogen nor from spreading it to others.
Professor Ball commented that the whole trial should be re-considered. Professor Robin Shattock, head of mucosal infection and immunity at Imperial College London suggests no vaccine will be available—at least widely—until sometime in 2021. He told BBC Radio 4 he is upbeat about the prognosis of a vaccine as the target is a lot well known now."
Sign In
Follow the stocks
